Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by sah1


PFSCF

RE:RE:RE:short term

This baby is not only over pregnant but way overdue. It's got to drop...

January 11, 2017

PFSCF

RE:RE:RE:short term

Agree. let's hope it happens in Q1 and not H1.

January 11, 2017

PFSCF

RE:short term

Short term catalysts include: - Read out from Alstrom study (Jan) -Read out...

January 11, 2017

PFSCF

RE:IPF

Agree, Mitch. We can't overlook the fact that 4050 in combo with...

January 11, 2017

PFSCF

RE:RE:IPF developments

Stag, the 4050 results could well be out before the Roche and Boehringer...

January 11, 2017

PFSCF

IPF developments

The second read out from PLI's open label trial involving 41 patients is...

January 11, 2017

PFSCF

RE:RE:RE:How about "enough of the short talk"

Eddy Suntan, please tell me you have bet your shirt on shorting PLI or at...

January 11, 2017

PFSCF

RE:Blocking Shares from Shorters

What if you put your PLI shares into a non-margin account?

January 10, 2017

PFSCF

RE:Late trading 15:24 - 16:00

PLI is probably in San Fran for the JP Morgan annual HealthCare conference...

January 10, 2017

PFSCF

RE:Pg BLA re: types 1 & 2 PgCD

Thanks for this, Bob. Let's hope the FDA approves A BLA for Types 1&2...

January 10, 2017

PFSCF

RE:RE:RE:RE:RE:RE:RE:RE:revenue expectations management

I agree 100%.

January 9, 2017

PFSCF

RE:RE:RE:RE:RE:RE:revenue expectations management

Hi Barcode, I agree about the number of Type 2 deficient patients being way...

January 9, 2017

PFSCF

RE:RE:RE:RE:revenue expectations management

Bob, I hope you are right on the $25m and that the marketing department finds...

January 9, 2017

PFSCF

RE:RE:revenue expectations management

Bob, in order to get Pg revenues of $8-10m for 2017, PLI will need to get at...

January 9, 2017

PFSCF

RE:RE:revenue expectations management

Agree Nomade about 2020 being the year PLI becomes a complete vertically...

January 9, 2017

PFSCF

revenue expectations management

While I am enthralled by the opportunity presented by Pg in its many...

January 9, 2017

PFSCF

Burn Treatment Centres USA

Not hard to identify the target market! https://en.wikipedia.org/wiki/List...

January 8, 2017

PFSCF

RE:RE:Bloom Burton and Co. comments on ProMetic Life Sciences Inc.

I agree, Francois. However, I would be interested in knowing the number of Pg...

January 5, 2017

PFSCF

RE:RE:RE:RE:News! :))

Yes, a couple of regional deals on 4050 with significant $$$ upfront will...

January 5, 2017

PFSCF

RE:RE:News! :))

I'm happy with this deal. If Pg deficiency revenues approach $200M at...

January 5, 2017

Featured Company